nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—CHRM3—muscle of abdomen—Crohn's disease	0.0657	0.239	CbGeAlD
Propiomazine—HTR2A—enteric nervous system—Crohn's disease	0.0616	0.224	CbGeAlD
Propiomazine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0467	0.17	CbGeAlD
Propiomazine—CHRM5—epithelium—Crohn's disease	0.014	0.0509	CbGeAlD
Propiomazine—CHRM5—skin of body—Crohn's disease	0.0133	0.0484	CbGeAlD
Propiomazine—ADRA1D—epithelium—Crohn's disease	0.0125	0.0455	CbGeAlD
Propiomazine—CHRM3—smooth muscle tissue—Crohn's disease	0.00754	0.0274	CbGeAlD
Propiomazine—ADRA1A—epithelium—Crohn's disease	0.00719	0.0261	CbGeAlD
Propiomazine—CHRM3—digestive system—Crohn's disease	0.00595	0.0216	CbGeAlD
Propiomazine—HRH1—epithelium—Crohn's disease	0.00556	0.0202	CbGeAlD
Propiomazine—ADRA1A—lymphoid tissue—Crohn's disease	0.00553	0.0201	CbGeAlD
Propiomazine—HRH1—smooth muscle tissue—Crohn's disease	0.00536	0.0195	CbGeAlD
Propiomazine—HRH1—mammalian vulva—Crohn's disease	0.00483	0.0175	CbGeAlD
Propiomazine—HTR2A—epithelium—Crohn's disease	0.00465	0.0169	CbGeAlD
Propiomazine—HTR2A—smooth muscle tissue—Crohn's disease	0.00448	0.0163	CbGeAlD
Propiomazine—HRH1—digestive system—Crohn's disease	0.00423	0.0154	CbGeAlD
Propiomazine—HTR2A—digestive system—Crohn's disease	0.00353	0.0128	CbGeAlD
Propiomazine—HRH1—lymph node—Crohn's disease	0.00242	0.00878	CbGeAlD
Propiomazine—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	0.00018	0.000248	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	0.000179	0.000248	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	0.000179	0.000247	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—RBX1—Crohn's disease	0.000178	0.000245	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	0.000177	0.000244	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—RBX1—Crohn's disease	0.000175	0.000241	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	0.000175	0.000241	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—RBX1—Crohn's disease	0.000174	0.000241	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000174	0.00024	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000174	0.00024	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000173	0.000239	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	0.000173	0.000239	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—JAK2—Crohn's disease	0.000173	0.000238	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000172	0.000237	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.000172	0.000237	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	0.000172	0.000237	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000171	0.000236	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000171	0.000236	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	0.000171	0.000236	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	0.000171	0.000236	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	0.000171	0.000236	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000171	0.000236	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000171	0.000236	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	0.00017	0.000235	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.00017	0.000235	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	0.00017	0.000235	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	0.00017	0.000234	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000169	0.000234	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	0.000169	0.000233	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	0.000169	0.000233	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000169	0.000233	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000169	0.000233	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	0.000169	0.000233	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000168	0.000232	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000167	0.000231	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL3—Crohn's disease	0.000167	0.00023	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	0.000167	0.00023	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000164	0.000226	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—SMAD3—Crohn's disease	0.000164	0.000226	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	0.000164	0.000226	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	0.000163	0.000225	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000163	0.000225	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	0.000162	0.000223	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000161	0.000223	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	0.000161	0.000222	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL3—Crohn's disease	0.00016	0.000221	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	0.000158	0.000218	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000156	0.000216	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	0.000156	0.000215	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	0.000156	0.000215	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000156	0.000215	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	0.000155	0.000214	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	0.000155	0.000213	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	0.000154	0.000213	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	0.000153	0.000212	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000153	0.000212	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	0.000153	0.000211	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000153	0.00021	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000152	0.00021	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL2RA—Crohn's disease	0.000152	0.00021	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	0.000151	0.000208	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000151	0.000208	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.00015	0.000207	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	0.00015	0.000207	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	0.000149	0.000206	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	0.000149	0.000205	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	0.000148	0.000205	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000148	0.000204	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000148	0.000204	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000147	0.000203	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL3—Crohn's disease	0.000147	0.000203	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000147	0.000202	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	0.000146	0.000202	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000146	0.000201	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	0.000146	0.000201	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.000146	0.000201	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL3—Crohn's disease	0.000145	0.0002	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL3—Crohn's disease	0.000145	0.0002	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000144	0.000199	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000144	0.000198	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.000143	0.000198	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	0.000143	0.000197	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000142	0.000196	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000142	0.000196	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000142	0.000196	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	0.00014	0.000194	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	0.00014	0.000193	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	0.00014	0.000193	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	0.00014	0.000193	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	0.00014	0.000193	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	0.000139	0.000192	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000139	0.000192	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000139	0.000192	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000138	0.00019	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000137	0.000189	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000137	0.000189	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	0.000135	0.000186	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000134	0.000185	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	0.000134	0.000184	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	0.000133	0.000184	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	0.000129	0.000178	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	0.000129	0.000178	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000128	0.000177	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	0.000127	0.000176	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000127	0.000176	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	0.000127	0.000175	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	0.000127	0.000175	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	0.000127	0.000175	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000127	0.000175	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000126	0.000174	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	0.000126	0.000174	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.000126	0.000174	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000126	0.000174	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000125	0.000172	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000125	0.000172	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000125	0.000172	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	0.000124	0.000172	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	0.000123	0.00017	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	0.000121	0.000168	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	0.000121	0.000167	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	0.000121	0.000167	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	0.000121	0.000167	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.00012	0.000166	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.00012	0.000166	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000119	0.000164	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	0.000119	0.000164	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000118	0.000163	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	0.000117	0.000162	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	0.000117	0.000161	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	0.000116	0.00016	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000116	0.00016	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000116	0.00016	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	0.000116	0.000159	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000116	0.000159	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	0.000115	0.000159	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000115	0.000159	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000115	0.000159	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.000115	0.000158	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000114	0.000157	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000114	0.000157	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000113	0.000157	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	0.000113	0.000156	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	0.000112	0.000154	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	0.000111	0.000154	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	0.00011	0.000151	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	0.000109	0.000151	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000109	0.000151	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000109	0.00015	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.000108	0.000149	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	0.000107	0.000148	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	0.000107	0.000148	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TYK2—Crohn's disease	0.000107	0.000148	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	0.000106	0.000146	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000105	0.000146	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	0.000105	0.000145	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000105	0.000145	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.000105	0.000144	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000104	0.000143	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000103	0.000142	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	0.000103	0.000142	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—JAK2—Crohn's disease	0.000102	0.000141	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	0.000102	0.00014	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	0.000101	0.00014	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	0.000101	0.000139	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000101	0.000139	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	0.000101	0.000139	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.000101	0.000139	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	9.97e-05	0.000138	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	9.95e-05	0.000137	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	9.64e-05	0.000133	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TYK2—Crohn's disease	9.63e-05	0.000133	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	9.5e-05	0.000131	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CXCL8—Crohn's disease	9.32e-05	0.000129	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	9.19e-05	0.000127	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—JAK2—Crohn's disease	9.19e-05	0.000127	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	9.07e-05	0.000125	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—IL6—Crohn's disease	8.86e-05	0.000122	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	8.8e-05	0.000121	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	8.74e-05	0.000121	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ALB—Crohn's disease	8.71e-05	0.00012	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	8.39e-05	0.000116	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	8.37e-05	0.000115	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	8.28e-05	0.000114	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	8.24e-05	0.000114	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—IL6—Crohn's disease	7.98e-05	0.00011	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	7.89e-05	0.000109	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	7.87e-05	0.000109	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	7.86e-05	0.000108	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PTGS2—Crohn's disease	7.62e-05	0.000105	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	7.53e-05	0.000104	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—STAT3—Crohn's disease	7.49e-05	0.000103	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	7.39e-05	0.000102	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TYK2—Crohn's disease	7.27e-05	0.0001	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	7.17e-05	9.9e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	7.16e-05	9.87e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TYK2—Crohn's disease	7.14e-05	9.85e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	7.12e-05	9.82e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	7.1e-05	9.79e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	7.08e-05	9.77e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	7.03e-05	9.69e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	7.01e-05	9.67e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—JAK2—Crohn's disease	6.94e-05	9.57e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	6.87e-05	9.48e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	6.83e-05	9.42e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	6.82e-05	9.41e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—JAK2—Crohn's disease	6.81e-05	9.4e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	6.79e-05	9.37e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	6.77e-05	9.34e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—STAT3—Crohn's disease	6.74e-05	9.31e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	6.7e-05	9.25e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	6.68e-05	9.22e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	6.65e-05	9.18e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	6.53e-05	9.01e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	6.33e-05	8.74e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	6.23e-05	8.6e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	6.22e-05	8.58e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	6.2e-05	8.55e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	6.18e-05	8.52e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	6.12e-05	8.44e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	6.1e-05	8.42e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL6—Crohn's disease	6.02e-05	8.31e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	5.92e-05	8.17e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL6—Crohn's disease	5.91e-05	8.16e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	5.89e-05	8.13e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	5.87e-05	8.1e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	5.82e-05	8.03e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	5.8e-05	8e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	5.77e-05	7.96e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	5.52e-05	7.62e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL6—Crohn's disease	5.23e-05	7.22e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL6—Crohn's disease	5.16e-05	7.12e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—STAT3—Crohn's disease	5.09e-05	7.03e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	5.01e-05	6.91e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—STAT3—Crohn's disease	5e-05	6.9e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	4.98e-05	6.88e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	4.97e-05	6.85e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL6—Crohn's disease	4.94e-05	6.82e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	4.92e-05	6.79e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	4.91e-05	6.77e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL6—Crohn's disease	4.71e-05	6.5e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	4.65e-05	6.41e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL6—Crohn's disease	4.03e-05	5.56e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	3.86e-05	5.32e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL6—Crohn's disease	3.56e-05	4.91e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL6—Crohn's disease	3.5e-05	4.83e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL6—Crohn's disease	3.49e-05	4.82e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL6—Crohn's disease	3.48e-05	4.8e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL6—Crohn's disease	3.47e-05	4.79e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL6—Crohn's disease	3.44e-05	4.74e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	3.43e-05	4.73e-05	CbGpPWpGaD
